Registry Data Show Vedolizumab, Ustekinumab Safe in Pregnancy

$ 9.50

4.7
(550)
In stock
Description

IBD and Pregnancy: Frequently Asked Questions - Canadian Digestive Health Foundation

Ustekinumab

AR - Stelara (Ustekinumab), PDF, Ulcerative Colitis

Vincent S. Panella on LinkedIn: Registry-Data-Show-Vedolizumab

JCM, Free Full-Text

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease

Full article: Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up

Evidence corner

Full article: Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy

Ustekinumab in Dermatology: Approved Indications and Off-label Uses

Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid, BMC Gastroenterology

Sunanda Kane, MD, on Moderate, Severe, and Refractory Crohn's Disease

A review article of inflammatory bowel disease treatment and pharmacogenomics, Beni-Suef University Journal of Basic and Applied Sciences

Efficacy and Safety of Ustekinumab for CD

PDF) Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study